Cholangioadenoma
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| RALOX as Second Line Treatment for Advanced Malignant Biliary System Tumor (NCT05148143) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2020-06-01 |
Track Cholangioadenoma automatically
Every clearance here is in the API, with alerts when new ones post.